Clinical and economic impact of the taurolidine lock on home parenteral nutrition

Abstract Introduction: catheter-related bloodstream infections (CRBSI) are one of the most serious concerns in patients on home parenteral nutrition (HPN) which involve high morbidity and cost for the healthcare system. In the last years, taurolidine lock has proven to be beneficial in the prevention of CRBSI; however, the evidence of its efficiency is limited. Objective: to determine if taurolidine lock is a cost-effective intervention in patients on HPN. Materials and methods: retrospective study in patients on HPN with taurolidine lock. We compared the CRBSI rate and cost of its complications before and during taurolidine lock. Results: thirteen patients, six (46%) males and seven (54%) females, with a mean age of 61.08 (SD = 14.18) years received taurolidine lock. The total days of catheterization pre and per-taurolidine were 12,186 and 5,293, respectively. The underlying disease was benign in five patients (38.5%) and malignant in eight (61.5%). The CRBSI rate pre vs per-taurolidine was 3.12 vs 0.76 episodes per 1,000 catheter days (p = 0.0058). When the indication was a high CRBSI rate, this was 9.72 vs 0.39 (p < 0.001) in pre and per-taurolidine period respectively. No differences have been observed in the occlusion rates. None of the patients reported any adverse effects. The total cost of CRBSI in the pre-taurolidine period was 151,264.14 euros vs 24,331.19 euros in the per-taurolidine period. Conclusions: our study shows that taurolidine lock is a cost-effective intervention in patients on HPN with high risk of CRBSI.

Saved in:
Bibliographic Details
Main Authors: Arnoriaga Rodríguez,María, Pérez de Ciriza Cordeu,Maite, Camblor Álvarez,Miguel, Bretón Lesmes,Irene, Motilla de la Cámara,Marta, Velasco Gimeno,Cristina, Arhip,Loredana, García Peris,Pilar, Cuerda Compés,Cristina
Format: Digital revista
Language:English
Published: Grupo Arán 2018
Online Access:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112018000800003
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0212-16112018000800003
record_format ojs
spelling oai:scielo:S0212-161120180008000032021-04-21Clinical and economic impact of the taurolidine lock on home parenteral nutritionArnoriaga Rodríguez,MaríaPérez de Ciriza Cordeu,MaiteCamblor Álvarez,MiguelBretón Lesmes,IreneMotilla de la Cámara,MartaVelasco Gimeno,CristinaArhip,LoredanaGarcía Peris,PilarCuerda Compés,Cristina Taurolidine Home parenteral nutrition (HPN) Central venous catheter (CVC) Catheter-related bloodstream infection (CRBSI) Costs Abstract Introduction: catheter-related bloodstream infections (CRBSI) are one of the most serious concerns in patients on home parenteral nutrition (HPN) which involve high morbidity and cost for the healthcare system. In the last years, taurolidine lock has proven to be beneficial in the prevention of CRBSI; however, the evidence of its efficiency is limited. Objective: to determine if taurolidine lock is a cost-effective intervention in patients on HPN. Materials and methods: retrospective study in patients on HPN with taurolidine lock. We compared the CRBSI rate and cost of its complications before and during taurolidine lock. Results: thirteen patients, six (46%) males and seven (54%) females, with a mean age of 61.08 (SD = 14.18) years received taurolidine lock. The total days of catheterization pre and per-taurolidine were 12,186 and 5,293, respectively. The underlying disease was benign in five patients (38.5%) and malignant in eight (61.5%). The CRBSI rate pre vs per-taurolidine was 3.12 vs 0.76 episodes per 1,000 catheter days (p = 0.0058). When the indication was a high CRBSI rate, this was 9.72 vs 0.39 (p < 0.001) in pre and per-taurolidine period respectively. No differences have been observed in the occlusion rates. None of the patients reported any adverse effects. The total cost of CRBSI in the pre-taurolidine period was 151,264.14 euros vs 24,331.19 euros in the per-taurolidine period. Conclusions: our study shows that taurolidine lock is a cost-effective intervention in patients on HPN with high risk of CRBSI.Grupo AránNutrición Hospitalaria v.35 n.4 20182018-08-01journal articletext/htmlhttp://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112018000800003en
institution SCIELO
collection OJS
country España
countrycode ES
component Revista
access En linea
databasecode rev-scielo-es
tag revista
region Europa del Sur
libraryname SciELO
language English
format Digital
author Arnoriaga Rodríguez,María
Pérez de Ciriza Cordeu,Maite
Camblor Álvarez,Miguel
Bretón Lesmes,Irene
Motilla de la Cámara,Marta
Velasco Gimeno,Cristina
Arhip,Loredana
García Peris,Pilar
Cuerda Compés,Cristina
spellingShingle Arnoriaga Rodríguez,María
Pérez de Ciriza Cordeu,Maite
Camblor Álvarez,Miguel
Bretón Lesmes,Irene
Motilla de la Cámara,Marta
Velasco Gimeno,Cristina
Arhip,Loredana
García Peris,Pilar
Cuerda Compés,Cristina
Clinical and economic impact of the taurolidine lock on home parenteral nutrition
author_facet Arnoriaga Rodríguez,María
Pérez de Ciriza Cordeu,Maite
Camblor Álvarez,Miguel
Bretón Lesmes,Irene
Motilla de la Cámara,Marta
Velasco Gimeno,Cristina
Arhip,Loredana
García Peris,Pilar
Cuerda Compés,Cristina
author_sort Arnoriaga Rodríguez,María
title Clinical and economic impact of the taurolidine lock on home parenteral nutrition
title_short Clinical and economic impact of the taurolidine lock on home parenteral nutrition
title_full Clinical and economic impact of the taurolidine lock on home parenteral nutrition
title_fullStr Clinical and economic impact of the taurolidine lock on home parenteral nutrition
title_full_unstemmed Clinical and economic impact of the taurolidine lock on home parenteral nutrition
title_sort clinical and economic impact of the taurolidine lock on home parenteral nutrition
description Abstract Introduction: catheter-related bloodstream infections (CRBSI) are one of the most serious concerns in patients on home parenteral nutrition (HPN) which involve high morbidity and cost for the healthcare system. In the last years, taurolidine lock has proven to be beneficial in the prevention of CRBSI; however, the evidence of its efficiency is limited. Objective: to determine if taurolidine lock is a cost-effective intervention in patients on HPN. Materials and methods: retrospective study in patients on HPN with taurolidine lock. We compared the CRBSI rate and cost of its complications before and during taurolidine lock. Results: thirteen patients, six (46%) males and seven (54%) females, with a mean age of 61.08 (SD = 14.18) years received taurolidine lock. The total days of catheterization pre and per-taurolidine were 12,186 and 5,293, respectively. The underlying disease was benign in five patients (38.5%) and malignant in eight (61.5%). The CRBSI rate pre vs per-taurolidine was 3.12 vs 0.76 episodes per 1,000 catheter days (p = 0.0058). When the indication was a high CRBSI rate, this was 9.72 vs 0.39 (p < 0.001) in pre and per-taurolidine period respectively. No differences have been observed in the occlusion rates. None of the patients reported any adverse effects. The total cost of CRBSI in the pre-taurolidine period was 151,264.14 euros vs 24,331.19 euros in the per-taurolidine period. Conclusions: our study shows that taurolidine lock is a cost-effective intervention in patients on HPN with high risk of CRBSI.
publisher Grupo Arán
publishDate 2018
url http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112018000800003
work_keys_str_mv AT arnoriagarodriguezmaria clinicalandeconomicimpactofthetaurolidinelockonhomeparenteralnutrition
AT perezdecirizacordeumaite clinicalandeconomicimpactofthetaurolidinelockonhomeparenteralnutrition
AT cambloralvarezmiguel clinicalandeconomicimpactofthetaurolidinelockonhomeparenteralnutrition
AT bretonlesmesirene clinicalandeconomicimpactofthetaurolidinelockonhomeparenteralnutrition
AT motilladelacamaramarta clinicalandeconomicimpactofthetaurolidinelockonhomeparenteralnutrition
AT velascogimenocristina clinicalandeconomicimpactofthetaurolidinelockonhomeparenteralnutrition
AT arhiploredana clinicalandeconomicimpactofthetaurolidinelockonhomeparenteralnutrition
AT garciaperispilar clinicalandeconomicimpactofthetaurolidinelockonhomeparenteralnutrition
AT cuerdacompescristina clinicalandeconomicimpactofthetaurolidinelockonhomeparenteralnutrition
_version_ 1755936997469323264